Literature DB >> 24272605

Study of tonsillectomy for IgA nephropathy patients: short- and longer-term observation.

Yuyuan Liu1, Hong Liu, Xiwen Tu, Youming Peng, Fuyou Liu, Fan Zhang, Chunyan Guo, Yang Liu, Xinming Yang, Guochun Chen, Yinghong Liu, Fang Yuan.   

Abstract

OBJECTIVE: We observed serum parameters and urinary findings of IgA nephropathy (IgAN) patients in the short and longer time after tonsillectomy, to provide evidences to clarify the role of tonsils in the pathogenesis of IgAN and the feasibility of tonsillectomy for IgAN patients.
METHODS: For the short-term study, 19 patients with both IgAN and chronic tonsillitis (group A) and 19 patients with chronic tonsillitis (group B) were performed bilateral tonsillectomy and 19 healthy people as normal controls (group C). Another 115 patients with IgAN and chronic tonsillitis including 61 patients for tonsillectomy combined with drug therapy and 54 for drug therapy alone followed up for 12 months.
RESULTS: Fourteen patients of group A showed a deterioration of urinary findings, while only 2 patients of group B showed deterioration (P < 0.01). Both serum IgA and IgA1 levels were significantly higher in group A than that in group B or group C (P < 0.05, respectively). Levels of serum IgA and IgA1 of group A increased after tonsillectomy and did not increase instantly, but increased at day 3, then decreased at day 5. Both serum IgA and IgA1 levels were positively related to urinary red blood cell count (P < 0.01, r s = 0.362, r s = 0.347, respectively). For longer-term study, urinary findings of IgAN patients underwent tonsillectomy were improved significantly than that of patients without tonsillectomy (P < 0.05).
CONCLUSION: Tonsils play an important role in the development of IgAN, and tonsillectomy may be a feasible treatment method for IgAN patients with chronic tonsillitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24272605     DOI: 10.1007/s11255-013-0606-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 2.  Structure and function relationships in IgA.

Authors:  J M Woof; M W Russell
Journal:  Mucosal Immunol       Date:  2011-09-21       Impact factor: 7.313

Review 3.  The mucosa-bone-marrow axis in IgA nephropathy.

Authors:  Yusuke Suzuki; Yasuhiko Tomino
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

Review 4.  Primary IgA nephropathy: new insights into pathogenesis.

Authors:  Jonathan Barratt; John Feehally
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

Review 5.  IgA production and tonsillar focal infection in IgA nephropathy.

Authors:  Hongxue Meng; Hiroya Ohtake; Akihiro Ishida; Nobuo Ohta; Seiji Kakehata; Mitsunori Yamakawa
Journal:  J Clin Exp Hematop       Date:  2012

Review 6.  The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?

Authors:  Jürgen Floege
Journal:  Am J Kidney Dis       Date:  2011-08-26       Impact factor: 8.860

7.  Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.

Authors:  Yi-Zhi Chen; Qing Gao; Xue-Zhi Zhao; Xiang-Mei Chen; Feng Zhang; Jing Chen; Cheng-Gang Xu; Lin-Lin Sun; Chang-Lin Mei
Journal:  Intern Med       Date:  2010-10-01       Impact factor: 1.271

8.  Recent progress in research on Tripterygium: a male antifertility plant.

Authors:  Q S Zhen; X Ye; Z J Wei
Journal:  Contraception       Date:  1995-02       Impact factor: 3.375

Review 9.  Hematuria and risk for end-stage kidney disease.

Authors:  Asaf Vivante; Ronit Calderon-Margalit; Karl Skorecki
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

10.  Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

Authors:  A W van den Wall Bake; W E Beyer; J H Evers-Schouten; J Hermans; M R Daha; N Masurel; L A van Es
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  4 in total

1.  Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan.

Authors:  Takahito Moriyama; Hiroshi Kataoka; Kosaku Nitta; Keita Hirano; Keiichi Matsuzaki; Takashi Yasuda; Yoshinari Yasuda; Kentaro Koike; Shoichi Maruyama; Takashi Yokoo; Seiichi Matsuo; Tetsuya Kawamura; Yusuke Suzuki
Journal:  Clin Exp Nephrol       Date:  2020-09-03       Impact factor: 2.801

2.  Characteristics of IgA nephropathy in advanced-age patients.

Authors:  Yasuko Oshima; Takahito Moriyama; Mitsuyo Itabashi; Takashi Takei; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2014-11-12       Impact factor: 2.370

3.  CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study.

Authors:  Hongdong Huang; Weiming Sun; Yumei Liang; Youming Peng; Xi-Dai Long; Zhihua Liu; Xiaojun Wen; Meng Jia; Ru Tian; Chengli Bai; Cui Li
Journal:  Int Urol Nephrol       Date:  2014-10-04       Impact factor: 2.370

4.  microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.

Authors:  Chan Liu; Mu-Yao Ye; Wen-Zhe Yan; Xiao-Fei Peng; Li-Yu He; You-Ming Peng
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.